Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02941666 · ClinicalTrials.gov registry record
Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 20
- Enrollment target
NCT02941666: Clinical Trial study, sponsored by Mayo Clinic.
NCT02941666 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02941666 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Previous studies have shown an increase in the concentration of mesenchymal stem cells (MSC's) in the setting of osteoarthritis of the knee and its correlation to severity. Researchers have shown that as there is an increase in the severity of the disease, the concentration of stem cells also increases. The purpose of this study is to determine if there is the same increase in stem cell concentration in patients with osteonecrosis (ON) of the femoral head.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-09 |
| Est. Completion | 2022-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02941666
The ClinicalTrials.gov registry entry for NCT02941666 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02941666 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02941666 about?
NCT02941666 is a clinical study titled "Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip". Previous studies have shown an increase in the concentration of mesenchymal stem cells (MSC's) in the setting of osteoarthritis of the knee and its correlation to severity. Researchers have shown that as there is an increase in the severity of the disease, the concentration of stem cells also increa...
What is the current status of trial NCT02941666?
This trial is currently terminated. The enrollment target is 20 participants. The study started on 2016-09. Estimated completion is 2022-05.
Who is sponsoring clinical trial NCT02941666?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.